Main Sequence Ventures has thrown its weight behind Nourish’s $11m funding round, which was co-led by Horizon Ventures.

Cambridge Innovation Capital has returned for a series C round for University of Cambridge-linked Gyroscope Therapeutics, which also welcomed back Syncona.

Helsinn and Johnson & Johnson returned to add $21m in extra funding to the $44m series B round the Purdue spinout closed in 2018.

The University of Utah spinout is looking to float on the Nasdaq Global Select Market and has filed with a $100m placeholder amount.

Evidation, co-founded by Stanford University and GE Ventures, has picked up series E funding at a $1bn valuation.

Cambridge Enterprise is celebrating another win with the acquisition of Smap Energy by Enechange.

The gene therapy developer focused on cardiovascular and central nervous system diseases will merge with Chardan Healthcare Acquisition 2 Corp to list on NYSE.

Stuart Therapeutics has collected equity financing from investors including Wisconsin Alumni Research Foundation to fund phase 2 trials for a drug aimed at dry eye disease.

The portfolio’s fair value rose by 21% and pre-tax profits are up 45% in the first half of Frontier IP’s fiscal year.

Stefanie Tompkins, Colorado School of Mines’ vice-president for research and technology transfer, has been appointed director of Darpa.